BASF rolls out in-house predictive tox testing tech as service
German chemicals giant BASF has made its in-house predictive toxicology testing tech available as a suite of services.
German chemicals giant BASF has made its in-house predictive toxicology testing tech available as a suite of services.
Bayer is trying to protect its manufacturing process for a chewable drug delivery dosage form with a US patent application.
Submitting a REMS (Risk Evaluation and Mitigation Strategies) proposal for risky drug developments could earn companies brownie points, according to Quintiles’ Ed Tabor.
SGS’ has opened a new cell-based assay laboratory in Poitiers, France in its latest European, biopharma-focused investment.
in-PharmaTechnologist.com presents its latest line-up of the new appointments within the industry, including news from Abbott, Trophos and the NIH.
SAFC has coupled its chiral screening and small-scale purification services to meet what it says is a boom in demand for more complete chemical analysis from drugmakers.
Clear communication between sponsors, CROs and regulators is critical to the smooth transfer of IRB responsibilities, the FDA said.
Eli Lilly will use its drug delivery device capabilities to boost the competitiveness of its developmental basal insulins, the firm’s SVP said.